Tebipenem pivoxil hydrobromide—No PICC, no problem!
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 748, doi. 10.1002/phar.2614
- By:
- Publication type:
- Article
Works matching IS 0277-0008 AND VI 41 AND IP 9 AND DT 2021
Results: 8
1
2
Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 743, doi. 10.1002/phar.2613
- By:
- Publication type:
- Article
3
Risk of fall‐related injury and all‐cause hospitalization of select concomitant central nervous system medication prescribing in older adult persistent opioid users: A case‐time‐control analysis.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 733, doi. 10.1002/phar.2612
- By:
- Publication type:
- Article
4
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 710, doi. 10.1002/phar.2610
- By:
- Publication type:
- Article
5
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 781, doi. 10.1002/phar.2609
- By:
- Publication type:
- Article
6
Hospitalizations for opioid‐related overdose and timing of concurrent opioid and benzodiazepine use: A nested case‐control study.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 722, doi. 10.1002/phar.2608
- By:
- Publication type:
- Article
7
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 762, doi. 10.1002/phar.2607
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 707, doi. 10.1002/phar.2291
- Publication type:
- Article